Serum levels of receptor activator of nuclear factor κB ligand (RANKL) in healthy women and men

被引:29
作者
Kerschan-Schindl, K. [1 ]
Wendlova, J. [2 ,3 ]
Kudlacek, S. [4 ]
Gleiss, A. [5 ]
Woloszczuk, W. [6 ]
Pietschmann, P. [7 ,8 ]
机构
[1] Med Univ Vienna, Dept Phys Med & Rehabil, A-1090 Vienna, Austria
[2] Univ Hosp, Osteol Unit, Bratislava, Slovakia
[3] Polyclin Kramare, Bratislava, Slovakia
[4] Krankenhaus Barmherzigen Brueder, Dept Internal Med, Vienna, Austria
[5] Core Unit Med Stat & Informat, Sect Clin Biometr, Vienna, Austria
[6] Ludwig Boltzmann Inst Rheumatol, Vienna, Austria
[7] Med Univ Vienna, Dept Pathophysiol, A-1090 Vienna, Austria
[8] Ludwig Boltzmann Inst Aging Res, Vienna, Austria
关键词
bone metabolism; free RANKL (receptor activator of nuclear factor kappa B ligand); total RANKL; age; gender;
D O I
10.1055/s-2007-993142
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Background: Osteoporosis is one of the most common conditions associated with aging. It is based on an excess of bone resorption over bone formation, leading to an imbalance of bone turnover. The receptor activator of nuclear factor kappa B ligand (RANKL) is ail important regulator of bone metabolism. Objective: The aim of this investigation was to evaluate potential age- and gender-related changes in free RANKL and total RANKL (free RANKL+ RANKL/osteoprotegerin complexes). Methods: Two hundred and forty Volunteers with a median age of 48 years were included in the study. Serum levels of free RANKL and total RANKL were evaluated. Results: On average, men have a 1.77-fold higher free RANKL level and a 2.12-fold higher free/total RANKL ratio than women of the same age. On average, the RANKL levels decrease by approximately 13 % every five years. Conclusion: This study showed that serum levels of free RANKL and total RANKL decrease with age, and also revealed some gender-related differences.
引用
收藏
页码:491 / 495
页数:5
相关论文
共 30 条
[1]
Increased RANKL/OPG mRNA ratio in iliac bone biopsies from women with hip fractures [J].
Abdallah, BM ;
Stilgren, LS ;
Nissen, N ;
Kassem, M ;
Jorgensen, HRI ;
Abrahamsen, B .
CALCIFIED TISSUE INTERNATIONAL, 2005, 76 (02) :90-97
[2]
Circulating amounts of osteoprotegerin and RANK ligand: Genetic influence and relationship with BMD assessed in female twins [J].
Abrahamsen, B ;
Hjelmborg, JV ;
Kostenuik, P ;
Stilgren, LS ;
Kyvik, K ;
Adamu, S ;
Brixen, K ;
Langdahl, BL .
BONE, 2005, 36 (04) :727-735
[3]
Cytokine production and lymphocyte subpopulations in aged humans. An assessment during nocturnal sleep [J].
Born, J ;
Uthgenannt, D ;
Dodt, C ;
Nunninghoff, D ;
Ringvolt, E ;
Wagner, T ;
Fehm, HL .
MECHANISMS OF AGEING AND DEVELOPMENT, 1995, 84 (02) :113-126
[4]
Role of RANK ligand in mediating increased bone resorption in early postmenopausal women [J].
Eghbali-Fatourechi, G ;
Khosla, S ;
Sanyal, A ;
Boyle, WJ ;
Lacey, DL ;
Riggs, BL .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (08) :1221-1230
[5]
TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts [J].
Fuller, K ;
Wong, B ;
Fox, S ;
Choi, YW ;
Chambers, TJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (05) :997-1001
[6]
Hawa Gerhard, 2003, Clin Lab, V49, P461
[7]
Effects of oral contraceptives on circulating osteoprotegerin and soluble RANK ligand serum levels in healthy young women [J].
Hofbauer, LC ;
Schoppet, M ;
Schüller, P ;
Viereck, V ;
Christ, M .
CLINICAL ENDOCRINOLOGY, 2004, 60 (02) :214-219
[8]
IKEDA T, 1995, BONE, V16, P17, DOI 10.1016/S8756-3282(94)00002-6
[9]
Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence [J].
Jilka, RL ;
Weinstein, RS ;
Takahashi, K ;
Parfitt, AM ;
Manolagas, SC .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (07) :1732-1740
[10]
Osteoprotegerin and receptor activator of nuclear factor-κB ligand (RANKL) in the serum of healthy adults [J].
Jung, K ;
Lein, M ;
Von Hösslin, K ;
Grosse, A ;
Roth, S ;
Possinger, K ;
Lüftner, D .
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2002, 17 (03) :177-181